Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs | ACS Medicinal Chemistry Letters
![PDF) Corrigendum to “Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding” [Bioorg. Med. Chem. Lett. 20 (2010) 657] | Lei Ma - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43569239/mini_magick20190215-11310-1dxjnl5.png?1550292595 "PDF) Corrigendum to “Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding” [Bioorg. Med. Chem. Lett. 20 (2010) 657] | Lei Ma - Academia.edu")
PDF) Corrigendum to “Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding” [Bioorg. Med. Chem. Lett. 20 (2010) 657] | Lei Ma - Academia.edu
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 1, Pages 1-240 (1 January 2016) | ScienceDirect.com by Elsevier
Ohkanda Research Lab | Chemical Biology, Shinshu University
PDF) 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8 | ACS Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry Letters | Vol 23, Issue 1, Pages 1-382 (1 January 2013) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Publications & Patents - The Trippier Lab
Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Dima Sabbah, Ph.D. PEER REVIEWED SCIENTIFIC ARTICLES (11SUBMITTED/ ACCEPTED/ PUBLISHED PEER REVIEWED ARTICLES) 1. Sweidan K.,
Targeting IRAK4 for Degradation with PROTACs | ACS Medicinal Chemistry Letters
CCHF | Publication
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors
The Dark Side of Fluorine | ACS Medicinal Chemistry Letters
![PDF) Corrigendum to “Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors” [Bioorg. Med. Chem. Lett. 16 (2006) 2411–2415] | Tai-An Lin - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/52287160/mini_magick20190123-29662-11w8dly.png?1548247061 "PDF) Corrigendum to “Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors” [Bioorg. Med. Chem. Lett. 16 (2006) 2411–2415] | Tai-An Lin - Academia.edu")
PDF) Corrigendum to “Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors” [Bioorg. Med. Chem. Lett. 16 (2006) 2411–2415] | Tai-An Lin - Academia.edu
Bioorganic & Medicinal Chemistry Letters | Journal | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier
Portfolio of hits — Laboratory of Medicinal Chemistry — Ghent University
PDF) Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2 '-hydroxy-3 '-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate
PROTAC Technology: Opportunities and Challenges | ACS Medicinal Chemistry Letters
